glp 1 oral or injectable Semaglutide Shows Promise in Adolescents with Type 2 Diabetes Oral GLP-1 Pill Delivers Injection-Like

Despite its efficacy, aspirins role in average-risk colorectal cancer prevention has narrowed

Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes

NCT01144338]

A 2022 NEJM trial showed participants on semaglutide lost an average of 15% body weight over 68 weeks

Decreasing glucose production keeps blood glucose under better control, and improving insulin sensitivity means the pancreas doesnt have to over work, which in the long term (10 years or so) can cause diabetes

The initial results of clinical trials have showcased the impressive weight loss benefits of GLP-1 analogues, such as semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide